These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21605009)

  • 1. EGFR upregulates inflammatory and proliferative responses in human lung adenocarcinoma cell line (A549), induced by lower dose of cadmium chloride.
    Kundu S; Sengupta S; Bhattacharyya A
    Inhal Toxicol; 2011 May; 23(6):339-48. PubMed ID: 21605009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB acts downstream of EGFR in regulating low dose cadmium induced primary lung cell proliferation.
    Kundu S; Sengupta S; Bhattacharyya A
    Biometals; 2013 Dec; 26(6):897-911. PubMed ID: 23948867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzo[a]pyrene promotes proliferation of human lung cancer cells by accelerating the epidermal growth factor receptor signaling pathway.
    Kometani T; Yoshino I; Miura N; Okazaki H; Ohba T; Takenaka T; Shoji F; Yano T; Maehara Y
    Cancer Lett; 2009 Jun; 278(1):27-33. PubMed ID: 19181443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.
    Petty WJ; Dragnev KH; Memoli VA; Ma Y; Desai NB; Biddle A; Davis TH; Nugent WC; Memoli N; Hamilton M; Iwata KK; Rigas JR; Dmitrovsky E
    Clin Cancer Res; 2004 Nov; 10(22):7547-54. PubMed ID: 15569985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
    Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
    Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling.
    Kobayashi S; Shimamura T; Monti S; Steidl U; Hetherington CJ; Lowell AM; Golub T; Meyerson M; Tenen DG; Shapiro GI; Halmos B
    Cancer Res; 2006 Dec; 66(23):11389-98. PubMed ID: 17145885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
    Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
    Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
    Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells.
    Chang GC; Yu CT; Tsai CH; Tsai JR; Chen JC; Wu CC; Wu WJ; Hsu SL
    Eur J Pharmacol; 2008 Dec; 600(1-3):37-44. PubMed ID: 18973751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib.
    de La Motte Rouge T; Galluzzi L; Olaussen KA; Zermati Y; Tasdemir E; Robert T; Ripoche H; Lazar V; Dessen P; Harper F; Pierron G; Pinna G; Araujo N; Harel-Belan A; Armand JP; Wong TW; Soria JC; Kroemer G
    Cancer Res; 2007 Jul; 67(13):6253-62. PubMed ID: 17616683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naphtho[1,2-b]furan-4,5-dione inactivates EGFR and PI3K/Akt signaling pathways in human lung adenocarcinoma A549 cells.
    Su JC; Lin KL; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR
    Life Sci; 2010 Jan; 86(5-6):207-13. PubMed ID: 20036260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
    Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
    Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ING4 induces cell growth inhibition in human lung adenocarcinoma A549 cells by means of Wnt-1/beta-catenin signaling pathway.
    Li X; Cai L; Liang M; Wang Y; Yang J; Zhao Y
    Anat Rec (Hoboken); 2008 May; 291(5):593-600. PubMed ID: 18399550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
    Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
    Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
    Zhang X; Yin P; DI D; Luo G; Zheng L; Wei J; Zhang J; Shi Y; Zhang J; Xu N
    Anticancer Res; 2009 Nov; 29(11):4497-501. PubMed ID: 20032397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long duration exposure to cadmium leads to increased cell survival, decreased DNA repair capacity, and genomic instability in mouse testicular Leydig cells.
    Singh KP; Kumari R; Pevey C; Jackson D; DuMond JW
    Cancer Lett; 2009 Jun; 279(1):84-92. PubMed ID: 19232459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor.
    Li J; Zhang L; Zhang J; Wei Y; Li K; Huang L; Zhang S; Gao B; Wang X; Lin P
    Carcinogenesis; 2013 Mar; 34(3):658-66. PubMed ID: 23250909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of ZD1839-induced G1-cell cycle arrest and apoptosis in human lung adenocarcinoma A549 cells.
    Chang GC; Hsu SL; Tsai JR; Liang FP; Lin SY; Sheu GT; Chen CY
    Biochem Pharmacol; 2004 Oct; 68(7):1453-64. PubMed ID: 15345335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
    Tong M; Ding Y; Tai HH
    Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells.
    Bai L; Zhu R; Chen Z; Gao L; Zhang X; Wang X; Bai C
    Biochem Pharmacol; 2006 Apr; 71(8):1265-71. PubMed ID: 16442503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.